Cargando…
Pulmonary artery pressure is associated with mid-term major adverse cardiovascular events and postprocedure pericardial effusion in atrial fibrillation patients undergoing left atrial appendage occlusion
BACKGROUND: Patients with nonvalvular atrial fibrillation (NVAF) undergoing left atrial appendage occlusion (LAAO) are at high risk of stroke or bleeding. However, risk factors for their adverse cardiovascular events remain largely unknown. Pulmonary hypertension has been shown to be related to poor...
Autores principales: | Zou, Tian, Chen, Qingxing, Zhang, Lei, Chen, Chaofeng, Ling, Yunlong, Liu, Guijian, Wang, Sunying, Pang, Yang, Xu, Ye, Cheng, Kuan, Zhou, Daxin, Zhu, Wenqing, Ge, Junbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422141/ https://www.ncbi.nlm.nih.gov/pubmed/34532461 http://dx.doi.org/10.21037/atm-21-3561 |
Ejemplares similares
-
Pericardial Effusion During the Perioperative Period for Left Atrial Appendage Closure
por: Yang, Lifan, et al.
Publicado: (2021) -
Moricizine prevents atrial fibrillation by late sodium current inhibition in atrial myocytes
por: Zou, Tian, et al.
Publicado: (2022) -
Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion
por: Wang, Xiaoyan, et al.
Publicado: (2021) -
Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion
por: Berti, Sergio, et al.
Publicado: (2022) -
Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion
por: Jeelani, Hafiz, et al.
Publicado: (2022)